These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29371200

  • 1. Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
    Wang WT, Hellkamp A, Doll JA, Thomas L, Navar AM, Fonarow GC, Julien HM, Peterson ED, Wang TY.
    J Am Heart Assoc; 2018 Jan 25; 7(3):. PubMed ID: 29371200
    [Abstract] [Full Text] [Related]

  • 2. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
    Giustino G, Colantonio LD, Brown TM, Carson AP, Dai Y, Farkouh ME, Monda KL, Muntner P, Rosenson RS.
    Cardiovasc Drugs Ther; 2018 Oct 25; 32(5):453-461. PubMed ID: 30078077
    [Abstract] [Full Text] [Related]

  • 3. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.
    Booth JN, Colantonio LD, Chen L, Rosenson RS, Monda KL, Safford MM, Kilgore ML, Brown TM, Taylor B, Dent R, Muntner P, Levitan EB.
    Circ Cardiovasc Qual Outcomes; 2017 Oct 25; 10(10):. PubMed ID: 29021332
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes with high-intensity statins according to atherothrombotic risk stratification after acute myocardial infarction: The FAST-MI registries.
    Desjobert E, Tea V, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E, FAST-MI investigators.
    Arch Cardiovasc Dis; 2021 Feb 25; 114(2):88-95. PubMed ID: 33011156
    [Abstract] [Full Text] [Related]

  • 5. Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
    Sakhuja S, Bittner VA, Brown TM, Farkouh ME, Levitan EB, Safford MM, Woodward M, Chen L, Sun R, Dhalwani N, Jones J, Kalich B, Exter J, Muntner P, Rosenson RS, Colantonio LD.
    Cardiovasc Drugs Ther; 2024 Oct 25; 38(5):937-945. PubMed ID: 37052867
    [Abstract] [Full Text] [Related]

  • 6. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801
    [Abstract] [Full Text] [Related]

  • 7. Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction.
    Booth JN, Colantonio LD, Rosenson RS, Safford MM, Chen L, Kilgore ML, Brown TM, Taylor B, Dent R, Monda KL, Muntner P, Levitan EB.
    J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739799
    [Abstract] [Full Text] [Related]

  • 8. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 9. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
    O'Donnell TFX, Deery SE, Darling JD, Shean KE, Mittleman MA, Yee GN, Dernbach MR, Schermerhorn ML.
    J Vasc Surg; 2017 Aug 04; 66(2):572-578. PubMed ID: 28506476
    [Abstract] [Full Text] [Related]

  • 10. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M, Al Danaf J, Panakos A, Ragupathi L, Duffy D, Whellan D.
    Am Heart J; 2016 Nov 04; 181():130-136. PubMed ID: 27823684
    [Abstract] [Full Text] [Related]

  • 11. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
    Virani SS, Kennedy KF, Akeroyd JM, Morris PB, Bittner VA, Masoudi FA, Stone NJ, Petersen LA, Ballantyne CM.
    Circ Cardiovasc Qual Outcomes; 2018 May 04; 11(5):e004652. PubMed ID: 29748356
    [Abstract] [Full Text] [Related]

  • 12. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 13. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.
    Circ Cardiovasc Qual Outcomes; 2019 Aug 03; 12(8):e005562. PubMed ID: 31416347
    [Abstract] [Full Text] [Related]

  • 14. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y, Navar AM, Li S, Li Z, Robinson J, Virani SS, Louie MJ, Koren A, Goldberg A, Roger VL, Wilson PWF, Peterson ED, Wang TY.
    J Am Heart Assoc; 2019 Oct 03; 8(19):e013229. PubMed ID: 31554462
    [Abstract] [Full Text] [Related]

  • 15. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
    Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U.
    Clin Res Cardiol; 2018 May 03; 107(5):380-388. PubMed ID: 29273856
    [Abstract] [Full Text] [Related]

  • 16. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T, Ishii H, Suzuki S, Shibata Y, Tatami Y, Harata S, Shimbo Y, Takayama Y, Tanaka A, Kawamura Y, Osugi N, Maeda K, Kondo T, Murohara T.
    Atherosclerosis; 2015 Sep 03; 242(1):155-60. PubMed ID: 26188539
    [Abstract] [Full Text] [Related]

  • 17. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
    Arca M, Ansell D, Averna M, Fanelli F, Gorcyca K, Iorga ŞR, Maggioni AP, Paizis G, Tomic R, Catapano AL.
    Atherosclerosis; 2018 Apr 03; 271():120-127. PubMed ID: 29499359
    [Abstract] [Full Text] [Related]

  • 18. Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
    Miedema MD, Garberich RF, Schnaidt LJ, Peterson E, Strauss C, Sharkey S, Knickelbine T, Newell MC, Henry TD.
    J Am Heart Assoc; 2017 Apr 12; 6(4):. PubMed ID: 28404560
    [Abstract] [Full Text] [Related]

  • 19. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž, De Backer G, Fras Z, Kotseva K, Tokgözoglu L, Wood D, De Bacquer D, EUROASPIRE Investigators.
    Atherosclerosis; 2016 Mar 12; 246():243-50. PubMed ID: 26812002
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Impact of Statin Intensity in Heart Failure Patients With Ischemic Heart Disease: A Report From the CHART-2 (Chronic Heart Failure Registry and Analysis in the Tohoku District 2) Study.
    Oikawa T, Sakata Y, Nochioka K, Miura M, Tsuji K, Onose T, Abe R, Kasahara S, Sato M, Shiroto T, Takahashi J, Miyata S, Shimokawa H, CHART‐2 invesigators.
    J Am Heart Assoc; 2018 Mar 14; 7(6):. PubMed ID: 29540427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.